Assignee
PHIGENIX INC
US·2 granted patents·10 pending applications·5 citations·filing 2009–2021
Top patents by PatentIndex Score
12 records- 0186US8722643B2Targeting EN2, PAX2, and/or DEFB1 for treatment of prostate conditionsPHIGENIX INC·Filed 2013·Granted May 13, 2014·5 cites·13 claims
- 0275US12064403B2Targeting PAX2 for the treatment of breast cancerPHIGENIX INC·Filed 2021·Granted Aug 20, 2024·0 cites·20 claims
- 0370US2020085967A1Targeting pax2 for the treatment of breast cancerPHIGENIX INC·Filed 2019·Application pending·0 cites
- 0464US2010029504A1Detecting pax2 for the diagnosis of breast cancerPHIGENIX INC·Filed 2009·Application pending·0 cites
- 0563US2014135378A1Targeting en2, pax2, and/or defb1 for treatment of prostate conditionsPHIGENIX INC·Filed 2014·Application pending·0 cites
- 0658US2011229467A1Targeting pax2 for the treatment of breast cancerPHIGENIX INC·Filed 2011·Application pending·0 cites
- 0758US2011206666A1Targeting pax2 for the treatment of breast cancerPHIGENIX INC·Filed 2011·Application pending·0 cites
- 0858US2011212089A1Targeting pax2 for the treatment of breast cancerPHIGENIX INC·Filed 2011·Application pending·0 cites
- 0958US2011206665A1Targeting pax2 for the treatment of breast cancerPHIGENIX INC·Filed 2011·Application pending·0 cites
- 1058US2011229468A1Targeting pax2 for the treatment of breast cancerPHIGENIX INC·Filed 2011·Application pending·0 cites
- 1147US2011229492A1Compositions and methods for diagnosing, treating, and preventing prostate conditionsPHIGENIX INC·Filed 2011·Application pending·0 cites
- 1240US2014323349A1Compositions and methods for monitoring and detecting cancerous conditionsPHIGENIX INC·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PHIGENIX INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →